Introduction: Characterizing the variations of the brain tumors has the significant effect in the treatment process of affected patients. Brain metastatic tumors are usually diagnosed following by the neurological symptoms in patients. The purpose of this thesis is the role of diffusion-weighted-magnetic resonance imaging (DW-MRI) and apparent diffusion coefficient (ADC) values in the evaluation of different benign and malignant brain mass lesions before surgery with histopathological correlation.
Materials and Methods: In this study MR examination of 54 patients who with brain metastatic tumor referring to 7th-Tir Hospital were randomly selected and imaged with T2W Multi-echo sequences and GRE-EPI (DWI) in addition to taking the routine sequence of the brain.
Results: In analyzing the data for ADCmin values were measured within the tumors and mean values were evaluated regarding statistical differences between groups.9 The ADCmin values of low-grade gliomas(1.09 ± 0.20 × 10−3 mm2/s) were significantly higher (p < .001) than those of other tumors. Generally, ADC value of 0.5613 ± 0.02580 indicates brain metastatic tumors with lung origin, ADC value of 1.009 ± 0.03820 tumors with liver and breast origin, and ADC value of 1.556 ± 0.03500 tumors with colon and prostate origin.
Conclusion: According to our results, Diffusion parameters during treatment were evaluated for early non-invasive biomarkers. The ADC changes from mid- to post-treatment suggest such a possible early non-invasive biomarker.
Keywords: Molecular Imaging, Apparent diffusion coefficient, Diffusion weighted imaging, Brain tumor.